The global GERD Drugs and Devices market is forecasted to be worth USD 6.14 Billion by 2027, according to a current analysis by Emergen Research. The market for Gastroesophageal Reflux Disease drugs and devices is expected to grow due to an increase in the incidences of acidic taste in the mouth, heartburn, dry cough, hoarseness, and asthma, among others. GERD drugs and devices consist of various medications, devise, and surgery.
The detailed market intelligence report on the GERD Drugs and Devices market applies the best of both primary and secondary research to weighs upon the competitive landscape and the prominent market players expected to dominate the GERD Drugs and Devices market for the forecast period, 2020 - 2027. The study not only scans through the company profile of the major vendors but also analyses their winning strategies to give business owners, stakeholders and field marketing personnel a competitive edge over others operating in the same space. A detailed evaluation of the major events such as acquisition and mergers, collaborations, product launches, new entrants, and technology advancements offer a complete overview of what the future of the XYZ market will be like in the years to come.
Gastroesophageal Reflux Disease is growing due to the intake of analgesics, smoking, decrease in the prevalence of Helicobacter pylori infection, consumption of certain types of food and drinks, high body mass index (BMI), family history of GERD, and limited physical activity. The growing incidence of the disease will drive the demand for the GERD drug and devices market.
Read more@ https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market
Key Highlights From The Report
November 2020, Sandoz Inc. announced it had shipped pantoprazole sodium to supply the hospitals for injection, 40 mg to Civica Rx. It is a part of a multiyear collaboration for the reduction in supply shortages with several other pipeline medicines.
H2 blockers are a group of drugs that reduces the amount of acid produced by the cell lining of the stomach. They are also known as histamine H2-receptor antagonists but are also known as H2 blockers. They include ranitidine, cimetidine, nizatidine, and famotidine, among others.
The MUSE or Medigus Ultrasonic Surgical Endostapler is an extensive endoscopic device that incorporates the latest technological advancement for the delivery of patient-friendly option for Transoral Fundoplication, the procedure intended for the treatment of GERD.
North America held the largest share, with the U.S. contributing the major revenue share. The rise in the geriatric population in the region, which is prone to acid reflux and development in heartburn, will drive the demand of the Gastroesophageal Reflux Disease Drugs and Devices market
Key participants include Johnson & Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Merck & CO., Inc., Boston Scientific Corporation, Eisai Co., Ltd., and Ironwood Pharmaceuticals, Inc., among others.
Request For Free Sample@ https://www.emergenresearch.com/request-sample/383
Route Of Administration Outlook (Revenue, USD Billion; 2017-2027)
Oral
Parenteral
Drug Type Outlook (Revenue, USD Billion; 2017-2027)
H2 Receptor Antagonist
Proton Pump Inhibitor (PPIs)
Antacids
Device Type Outlook (Revenue, USD Billion; 2017-2027)
MUSE –Medigus Ultrasonic Surgical Endostapler
LINX Management System
Stretta Therapy
Bravo Reflux Testing System
Digitrapper reflux testing system
Others
Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA
Table of Content
Chapter 1. Methodology & Sources
1.1. GERD Drugs and Devices Market Definition
1.2. GERD Drugs and Devices Market Research Scope
1.3. GERD Drugs and Devices Market Methodology
1.4. GERD Drugs and Devices Market Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. GERD Drugs and Devices Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. GERD Drugs and Devices Market Segmentation & Impact Analysis
Continued…
